Litcius/Paper detail

Teclistamab in relapsed or refractory AL amyloidosis: a multinational retrospective case series

Nathalie Forgeard, Dikélélé Elessa, Alexander Carpinteiro, Karim Belhadj, Monique C. Minnema, Murielle Roussel, Antoine Huart, Vincent Javaugue, Laurent Pascal, Bruno Royer, Alexis Talbot, Romain Gounot, Ute Hegenbart, Stefan Schönland, Lionel Karlin, Stéphanie Harel, Efstathios Kastritis, Frank Bridoux, Arnaud Jaccard, Bertrand Arnulf

2023Blood51 citationsDOIOpen Access PDF

Abstract

International audience

Topics & Concepts

AmyloidosisAL amyloidosisMedicineRefractory (planetary science)Series (stratigraphy)Internal medicineRetrospective cohort studyGastroenterologyImmunologyBiologyImmunoglobulin light chainAstrobiologyPaleontologyAntibodyAmyloidosis: Diagnosis, Treatment, OutcomesProtein Kinase Regulation and GTPase SignalingEosinophilic Disorders and Syndromes
Teclistamab in relapsed or refractory AL amyloidosis: a multinational retrospective case series | Litcius